Rockley Photonics Advances Non-Invasive Blood Glucose Monitoring
- Rockley has made rapid progress towards noninvasive optical measurement of glucose through benchtop and human studies.
- Measurement of glucose in simulated skin samples with Rockley’s proprietary photonic IC (PIC) chip technology, in a benchtop system resulted in a prediction accuracy of 5mg/dL.
- Rockley performed a rigorous human study involving 40 diabetic subjects over a 10-week period, which mitigated many common pitfalls of less advanced protocols.
- Rockley demonstrated the capability of its SWIR (short-wave infrared) measurement technique, including the requisite radiant powers, wavelength range, and optical resolution that are critical to enabling non-invasive glucose sensing in a wearable form factor
https://www.businesswire.com/news/home/20230926174458/en/Rockley-Photonics-Advances-Non-Invasive-Blood-Glucose-Monitoring
September 26, 2023 06:00 AM Eastern Daylight Time
OXFORD, England & IRVINE, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics continues to make rapid progress towards noninvasive glucose sensing using its proprietary silicon photonics platform. The technology platform enables short-wave infrared (SWIR) spectroscopy to be translated to a miniaturized, wearable form factor capable of making noninvasive biomarker measurements in humans. Through a combination of benchtop sensor verification with both simulated human skin and during preliminary human studies, Rockley has engineered the SWIR platform to measure glucose
